The forecasted R&D budget for Health and Medical Sciences in the US, expressed as a percentage of GDP, remains steady at 0.2% for 2024 and 2025, with a slight reduction to 0.19% from 2026 to 2028. Given the data, there is no year-on-year variation expected from 2024 to 2025, followed by a 5% decrease in 2026, stable at this level through 2028. The compound annual growth rate (CAGR) over the 2024-2028 period indicates stability with no significant change, at an average negative growth of about 0.252% annually. Although this suggests a minor contraction, it mainly reflects a stabilized investment level.

Future trends to watch for include:

Potential shifts in policy priorities impacting R&D allocations, especially as healthcare costs evolve.
Economic changes impacting GDP and potentially altering the relative R&D budget share.
Technological advancements necessitating increased R&D funding in certain areas.